Ovoca Bio Plc
Clinical-stage biopharma developing novel treatments for female sexual dysfunction.
OVXA | IR
Overview
Corporate Details
- ISIN(s):
- IE0006649010 (+1 more)
- LEI:
- 213800ST2AK5XQ1O5207
- Country:
- Ireland
- Address:
- 17 PEMBROKE STREET UPPER, D02 AT22 DUBLIN
- Website:
- https://ovocabio.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Ovoca Bio Plc is a clinical-stage biopharmaceutical company with a primary focus on women's health. The company is dedicated to developing novel treatments for female sexual dysfunction. Its lead product candidate, Orenetide (also known as BP-101), is a synthetic peptide designed for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women and has progressed to late-stage clinical development. Recent corporate activity indicates a potential strategic shift, with the company exploring a reverse takeover involving mining assets.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Ovoca Bio Plc and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-05 08:00 |
Delisting Announcement
Delisting from Euronext Growth Exchange
|
English | 9.0 KB | |
| 2025-03-03 15:00 |
Board/Management Information
Management Changes
|
English | 8.0 KB | |
| 2024-12-18 19:00 |
Post-Annual General Meeting Information
Result of AGM
|
English | 7.1 KB | |
| 2024-11-18 08:00 |
Pre-Annual General Meeting Information
Notice of AGM
|
English | 7.0 KB | |
| 2024-10-11 18:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 6.8 KB | |
| 2024-10-09 18:45 |
Transaction in Own Shares
Sale of Treasury Shares
|
English | 6.0 KB | |
| 2024-09-25 08:00 |
Report Publication Announcement
Half-year Report
|
English | 7.6 KB | |
| 2024-09-02 15:30 |
Related Party Transaction
Consultancy Agreement
|
English | 8.7 KB | |
| 2024-07-15 08:00 |
Director's Dealing
Director/PDMR Shareholding
|
English | 27.4 KB | |
| 2024-07-15 08:00 |
Board/Management Information
Directorate Change
|
English | 8.8 KB | |
| 2024-06-28 08:00 |
Report Publication Announcement
Annual Financial Report
|
English | 14.5 KB | |
| 2024-06-20 00:00 |
Annual Report
|
English | 1.2 MB | |
| 2024-01-23 08:00 |
Major Shareholding Notification
Holding(s) in Company
|
English | 7.9 KB | |
| 2023-12-01 13:00 |
Post-Annual General Meeting Information
Result of AGM
|
English | 7.8 KB | |
| 2023-11-07 10:15 |
Pre-Annual General Meeting Information
Notice of AGM
|
English | 8.3 KB |
Automate Your Workflow. Get a real-time feed of all Ovoca Bio Plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Ovoca Bio Plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
